{"doi":"10.1111/adb.12904","title":"Interactions between reinforcement history and drug‐primed reinstatement: Studies with MDPV and mixtures of MDPV and caffeine","abstract":"Abstract Many drugs of abuse are mixed with other psychoactive substances (e.g., caffeine) prior to their sale or use. Synthetic cathinones (e.g., 3,4‐methylenedioxypyrovalerone [MDPV]) are commonly mixed with caffeine or other cathinones (e.g., 3,4‐methylenedioxy‐ N ‐methylcathinone [methylone]), and these “bath salts” mixtures (e.g., MDPV + caffeine) can exhibit supra‐additive interactions with regard to their reinforcing and discriminative stimulus properties. However, little is known about relapse‐related effects of drug mixtures. In these studies, male Sprague–Dawley rats self‐administered 0.032 mg/kg/inf MDPV or a mixture of MDPV + caffeine (0.029 + 0.66 mg/kg/inf, respectively) and then underwent multiple rounds of extinction and reinstatement testing to evaluate the influence of reinforcement history and drug‐associated stimuli on the effectiveness of saline (drug‐paired stimuli alone), MDPV (0.032–1.0 mg/kg), caffeine (1.0–32 mg/kg), and mixtures of MDPV:caffeine (in 3:1, 1:1, and 1:3 ratios, relative to each drug's ED 50 ) to reinstate responding. Dose‐addition analyses were used to determine the nature of the drug–drug interaction for each mixture. MDPV and caffeine dose‐dependently reinstated responding and were equally effective, regardless of reinforcement history. Most fixed ratio mixtures of MDPV + caffeine exhibited supra‐additive interactions, reinstating responding to levels greater than was observed with caffeine and/or MDPV alone. Drug‐associated stimuli also played a key role in reinstating responding, especially for caffeine. Together, these results demonstrate that the composition of drug mixtures can impact relapse‐related effects of drug mixtures, and “bath salts” mixtures (MDPV + caffeine) may be more effective at promoting relapse‐related behaviors than the constituents alone. Further research is needed to determine how other polysubstance reinforcement histories can impact relapse‐related behaviors.","journal":"Addiction Biology","year":2020,"id":80155,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":15,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9555,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":415888,"name":"Agnieszka Sulima","orcid":"0000-0002-8849-9736","position":1,"is_corresponding":false},{"id":301852,"name":"Kenner C. Rice","orcid":"0000-0002-1147-9147","position":2,"is_corresponding":false},{"id":415889,"name":"Gregory T. Collins","orcid":"0000-0002-2499-3356","position":3,"is_corresponding":false},{"id":415887,"name":"Michelle R. Doyle","orcid":"0000-0003-4303-2478","position":0,"is_corresponding":true}],"reference_count":50,"raw_metadata":null,"created_at":"2026-07-18T21:51:24.704381Z","pmid":"32237282","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}